Gabapentin Capsule
Product Images NDC 76420-047

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 76420-047). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin-300mg-cap.jpg (Gabapentin 300mg Cap)

Gabapentin-300mg-cap.jpg (Gabapentin 300mg Cap)
This text appears to be listing Gabapentin Capsules, USP 300mg of different quantities and NDC codes. The capsules are distributed by Ascent Laboratories, LLC and have different lot numbers and drug stats (RX). There are also some codes that seem to correspond to storage and control of these capsules.*
FDA Label Image

Gabapentin 400mg Cap

Gabapentin 400mg Cap
This is a list of different packages of Gabapentin Capsules, USP 400mg that vary in the number of capsules they contain and their NDC codes, among other information regarding the manufacturer, lot numbers, and expiry dates of the capsules.*
FDA Label Image

Gabapentin-equation (Gabapentin Equation)

FDA Label Image

Gabapentin Fig1

Gabapentin Fig1
The text describes a chart or graph that shows the mean pain score for a study with a 4-week dose titration period and a 4-week fixed dose period. There is a comparison between a placebo group and a group taking Gabapentin at a dose of 3600 mg/day. The chart uses symbols to represent the results for each group over time. The baseline is also mentioned.*
FDA Label Image

Gabapentin Fig2

Gabapentin Fig2
The text is a table showing different pain scores for different doses of Gabapentin and a placebo over a period of weeks. It is not possible to generate a useful description as it lacks context and complete information.*
FDA Label Image

Gabapentin Fig3

Gabapentin Fig3
The text is describing a figure that shows the proportion of responders in controlled PHN studies, with various percentage ranges from 100% to 10%. The figure also includes data on different studies and medication dosages. There are some symbols and numbers that may belong to statistical analysis, but without context, it is not possible to determine their meaning.*
FDA Label Image

Gabapentin-fig4 (Gabapentin Fig4)

FDA Label Image

Str Fig05

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.